Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28360941 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL11551243 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL28413090 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL11194187 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL9744688 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL4627635 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL1302614 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL14744358 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL5937288 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL29005649 | 1.00 | CA2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025103475-A1 | HETEROCYCLIC CARBONYL DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-119111623-A | Preservative for corrosion prevention of perishable berries and preparation method thereof | 广西艾科宁消毒科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118994109-A | Preparation method of lysine-specific demethylase 1 inhibitor | 成都苑东生物制药股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117720521-A | Salt of nitrogen-containing heterocyclic ketone compound and preparation method thereof | 江苏豪森药业集团有限公司 | 2024-03-19 | — | — | CN | claimed |
| WO-2023154183-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY (US) | 2023-08-17 | — | — | WO | claimed |
| CN-111138413-B | Preparation method of cyclin-dependent kinase inhibitor and intermediate thereof | 江苏豪森药业集团有限公司 | 2022-11-04 | — | — | CN | claimed |
| US-20220272987-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY H (US) | 2022-09-01 | — | — | US | claimed |
| CN-111587728-A | Planting method of golden pears | 滁州市南谯区大柳镇良农金梨专业合作社 | 2020-08-28 | — | — | CN | claimed |
| CN-111138413-A | Preparation method and intermediate of cyclin-dependent kinase inhibitor | 江苏豪森药业集团有限公司 | 2020-05-12 | — | — | CN | claimed |
| US-20170273932-A1 | LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR | ZAFGEN INC (US) | 2017-09-28 | — | — | US | claimed |
| EP-3182960-A1 | LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR | Zafgen, Inc. (US) | 2017-06-28 | — | — | EP | claimed |
| WO-2016029206-A1 | LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR | ZAFGEN, INC. (US) | 2016-02-25 | — | — | WO | claimed |
| EP-0839024-B1 | MONENSIN FORMULATIONS | ELLI LILLY & CO NZ LTD (NZ) | 2004-04-21 | — | — | EP | claimed |
| EP-0839024-A4 | IONOPHORE ANTIBIOTIC FORMULATIONS | ELLI LILLY & CO NZ LIMITED (NZ) | 1999-01-27 | — | — | EP | claimed |
| EP-0839024-A1 | IONOPHORE ANTIBIOTIC FORMULATIONS | Elli Lilly & Co.(NZ)Limited (NZ) | 1998-05-06 | — | — | EP | claimed |
| WO-1997003650-A1 | IONOPHORE ANTIBIOTIC FORMULATIONS | ELI LILLY & COMPANY (NZ) LIMITED (NZ) | 1997-02-06 | — | — | WO | claimed |
| JP-10175834-A | — | — | None | — | — | JP | disclosed |
| JP-62292609-A | — | — | None | — | — | JP | disclosed |
| US-4149302-A | Monolithic semiconductor integrated circuit ferroelectric memory device | FERROSIL CORPORATION (US) | 1979-04-17 | — | — | US | disclosed |
| US-4149301-A | Monolithic semiconductor integrated circuit-ferroelectric memory drive | FERROSIL CORPORATION (US) | 1979-04-17 | — | — | US | disclosed |